INSULIN GLARGINE 300 U/ML VS. 100 U/ML IN OLDER PEOPLE WITH T2DM: RESULTS FROM A RANDOMIZED TRIAL

Antzeko izenburuak

• Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
  nork: Steinstraesser, A, et al.
  Argitaratua: (2014)
• Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672–1680
  nork: Ritzel, Robert, et al.
  Argitaratua: (2019)
• Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12‐month trial including 6‐month extension
  nork: Yki‐Järvinen, H., et al.
  Argitaratua: (2015)
• Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1‐year patient‐level meta‐analysis of the EDITION clinical studies in people with type 2 diabetes
  nork: Ritzel, Robert, et al.
  Argitaratua: (2017)
• Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)
  nork: Home, Philip D., et al.
  Argitaratua: (2017)